Strain Information | |
---|---|
Image | |
BRC No. | RBRC10013 |
Type | Transgene and Spontaneous Mutation![]() |
Species | Mus musculus |
Strain name | FVB-Invs<inv> Tg(EF1a-Invs/EGFP)D16/Daiw |
Former Common name | FVB.Inv::GFP CR-D16 |
H-2 Haplotype | |
ES Cell line | |
Background strain | |
Appearance | |
Strain development | |
Strain description | |
Colony maintenance | |
References | The left-right determinant Inversin is a component of node monocilia and other 9+0 cilia. Watanabe D, Saijoh Y, Nonaka S, Sasaki G, Ikawa Y, Yokoyama T, Hamada H Development, 130, 1725-1734 (2003). 12642479 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Invs MGI:1335082 | inversin | 4 | Invs<Invs> MGI:1856915 | inversion of embryonic turning | |||
EGFP | Enhanced Green Fluorescent Protein (Aequorea victoria) | UN | EGFP | ||||
Invs | inversin | UN | Invs | human elongation factor 1 alpha (EF-1 alpha) promoter | |||
loxP | phage P1 loxP | UN | loxP | ||||
loxP | phage P1 loxP | UN | loxP |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | Mouse tyrosinase cDNA, pUC119 DNA, SV40 origin and early promoter, human EEF1A1 promoter, Phage P1 loxP sites, mouse Inv cDNA, Aequorea victoria EGFP cDNA, human G-CSF 3' UTR and polyA |
Research application | Cre/loxP system Fluorescent Proteins/lacZ System |
Specific Term and Conditions | The RECIPIENT of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR. In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the following literature(s) designated by the DEPOSITOR is requested. Development, 130, 1725-1734 (2003). The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for profit institution for a not-for-profit research. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must reach agreement on terms and conditions of use of it with DEPOSITOR and must obtain a prior written consent from the DEPOSITOR. The RECIPIENT must contact the DEPOSITOR in case of application for any patents or for-profit use based o the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Daisuke Watanabe (Kitasato University) |
Strain Status | ![]() ![]() |
Strain Availability | Live mouse (3 to 6 months) |
Additional Info. | Necessary documents for ordering: |
BRC mice in Publications |
---|
No Data |